81 results about "Bergenia purpurascens" patented technology

The invention relates to a bergenia purpurascens(hook.f.et Thoms.)Engl. tender leaf tissue culture rapid propagation method. Under a natural wild condition, bergenia purpurascens(hook.f.et Thoms.)Engl. is low in emergence rate and has a low rhizome propagation coefficient, propagation by sowing seeds is low in emergence rate and has a low propagation coefficient, and cutting propagation can consume part of product organs, so that the production efficiency is reduced. The method comprises the following steps of: disinfecting and sterilizing an explant which serves as a raw material, performing induction culture to obtain callus, performing induction culture to obtain adventitious buds, performing proliferation culture on the buds, rooting culturing and hardening off seedlings and transplanting. The invention also provides formula of a culture medium used in the method. According to the method for performing tissue culture on bergenia purpurascens(hook.f.et Thoms.)Engl. tender leaves to generate seedlings, the seedlings of the bergenia purpurascens(hook.f.et Thoms.)Engl. tender leaves are more easily obtained when being compared with those from seeds and rhizomes, bergenia purpurascens(hook.f.et Thoms.)Engl. tender leaves are more easily obtained compared with seeds and rhizomes, and the propagation coefficient is high and not limited by the seasons and the climates; the demand for the seedlings on the production can be met at any time; furthermore, the tender leaf callus inductioncan be suitable for industrial production of various leaf medicinal components; moreover, the method is combined with an artificial mutation and transgenic technology, so that the germplasm can be improved, and a foundation is laid for the culture of new purple bergenia species.

The present invention discloses a qualitative and quantitative detection method of compound Japanese Ardisia Herb tablets, wherein microscopic identification of Japanese Ardisia Herb in the compound Japanese Ardisia Herb tablets is improved, thin-layer chromatography identification of Japanese Ardisia Herb, Dendranthema indicum and licorice root in the compound Japanese Ardisia Herb tablets is added, and a determination method of the bergenin content in the compound Japanese Ardisia Herb tablets is established. According to the qualitative and quantitative detection method, the identification is provided, wherein the microscopic identification method is adopted to identify the Japanese Ardisia Herb, and the thin-layer chromatography method is adopted to identify the Japanese Ardisia Herb, the Dendranthema indicum and the licorice root; the content determination is provided, wherein the high performance liquid chromatography method is adopted to determine the bergenin content in the Japanese Ardisia Herb; and the Japanese Ardisia Herb content in each compound Japanese Ardisia Herb tablet is not less than 1.5 mg (calculated as the bergenin (C14H16O9)). According to the present invention, with the method, the product quality controllability can be increased, and the shortcomings in the prior art can be overcome so as to well ensure the efficacy and provide good service for the majority of patients.

The invention discloses a method for determining the content of Kaihoujian spray (children type). The method for determining the content of sophocarpidine, bergenin, trifoliate pterocarpin and macaine in the Kaihoujian spray (children type) by adopting high performance liquid chromatography is established, and the content of Kaihoujian spray (children type) is determined by taking bergenin as an internal standard substance. The detection result is accurate and stable, and the method can be used for quality control of Kaihoujian spray (children type); meanwhile, the detection cost and the detection time can be reduced, the workload can be reduced, the efficiency can be improved, and a foundation is laid for improving the quality standard of kaihoujian spray (children type).

The invention relates to an anti-asthmatic and anti-inflammatory medicament and a preparation method and application thereof. The anti-asthmatic and anti-inflammatory medicament is made from the following raw materials in parts by weight: 5 to 8 parts of Ardisia crenata, 5 to 7 parts of Bergenia purpurascens, 1 to 3 parts of Tibetan hellebore, 5 to 7 parts of Crepis phoenix, 1 to 3 parts of Anemone rivularis, 2 to 4 parts of Herba Epimedii, 2 to 4 parts of Gentiana rhodantha and 3 to 4 parts of Polygonum cuspidatum. The medicament has the effects of removing heat and toxic substances, moistening the lung, stopping cough, relieving asthma and tonifying the kidney-yang; and has a high effective rate and a stable long-term efficacy.

The invention provides a traditional Chinese medicine composition for treating radiation proctitis, which is quick to take effect, good in effect and free from toxic and side effects and a preparation method thereof. The traditional Chinese medicine composition for treating radiation proctitis comprises the following raw material medicines by weight: 10-15g of Astilbe chinensis, 6-9g of dutchmanspipe root, 6-8g of Angelica sinensis, 12-15g of Ligusticum wallichii, 6-8g of Adenophora stricta, 10-15g of white hyacinth Bean, 6-8g of Rhizoma Atractylodis Macrocephalae, 9-15g of brookside astilbe, 9-15g of Bergenia crassifolia, 12-15g of medlar, 10-12g of Eclipta prostrate, 4-6g of liquorice, 10-15g of radix paeoniae alba, 15-30g of hairyvein agrimony, 15-20g of Cucurbitaceae, 15-18g of red umbilicaria, 9-12g of polygonum cillinerve ohwi, 5-10g of colla corii asini, 6-8g of pseudo-ginseng, 8-10g of radix scrophulariae, 10-15g of Scutellaria baicalensis and 9-12g of corydalis tuber. The preparation method of the traditional Chinese medicine composition comprises the following steps of: weighing the raw material medicines except pseudo-ginseng and colla corii asini; placing the raw material medicines in a marmite; adding 800ml of water to soak the raw material medicines; soaking for 60 minutes; decocting for 30 minutes by soft fire; filtering and obtaining a medicine liquid; then, adding 600ml of water, decocting for 20 minutes by soft fire, and obtaining a medicine liquid; grinding pseudo-ginseng and colla corii asini to fine powder, and then mixing the medicine liquids to obtain the composition.

The invention discloses a Kazakstan Tumaowu cold-rehabilitation traditional pharmaceutical composition for treating cold and a preparation method thereof. The pharmaceutical composition is combined with the the 'Six-element theory', namely 'alta turor' theory, 'vital energy, function and energy' theory', namely 'qwat' theory, 'body fluid' theory, namely 'sol' theory, and 'organ' theory, namely 'myfeler' theory, in the traditional medicinal theoretical basis 'Kazakstan Medicine Introduction', and has the main effect of preventing and treating diabetes mellitus. Traditional common medical plant rhamnus cathartica fruit in Kazakstan medicine, namely artemisia rupestris, hyssopus officinalis, trollflower and purple bergenia herb are extracted with water and ethanol, and uniformly mixed to prepare an internal preparation. The preparation can be decoction, pills, powder, granules, tablets and all other internal preparations for clinically preventing and treating viral, cold and other various colds. The medicinal composition has a particularly good curative effect on internal assistant treatment to cold, is reasonable in prescription, exact in curative effect, quick in response, no irritation or other toxic or side effect, and is convenient to prepare.

The invention discloses a traditional Chinese medicine preparation which has good treatment effect, no toxic or side effect and can radically cure the lung cancer without relapse. The traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 25 to 35 parts of stargrass, 10 to 25 parts of rattlesnake plantain, 15 to 35 parts of radix cirsii jeponici,15 to 25 parts of lemonfragrant ostericum root, 15 to 30 parts of psilotum nudum, 10 to 20 parts of dysosma versipellis, 10 to 20 parts of rhizoma pleionis, 20 to 40 parts of purple bergenia herb, 20to 40 parts of aconiteleaf syndeilesis herb and 20 to 40 parts of Chinese elm. The traditional Chinese medicine preparation is prepared from pure Chinese medicinal herbs, does not have any toxic or side effect, mainly utilizes the action for strengthening body resistance, reinforcing insufficiency and eliminating evil of the Chinese medicinal herbs, effectively induces tumour cells to be modified into normal cells, effectively improves the anticancer immunologic function of human bodies, regulates the integral function and the viscera function of the human bides and realizes the effects of inhibiting and killing cancer cells.

The invention discloses a pharmaceutical composition for preventing and controlling livestock diarrhea. The pharmaceutical composition is an agent prepared from the following raw medicinal materials in parts by weight: 1-4 parts of Chinese herbaceous peony, 1-5 parts of scutellaria baicalensis, 1-5 parts of coptis chinensis, 1-5 parts of angelica sinensis, 1-5 parts of rheum officinale, 1-5 parts of elecampane, 1-5 parts of betel nut, 1-5 parts of lonicerae flos, 1-5 parts of purslane, 1-5 parts of rhododendron micranthum leaf, 1-5 parts of polygonum viviparum, 1-4 parts of bergenia purpurascens and 1-4 parts of liquorice. Clinical veterinary use results prove that the medicine disclosed by the invention has an obvious effect used for treating diarrheal diseases of livestock such as yak, Tibetan sheep and the like. Moreover, compared with the current Western medicine used for treating livestock diarrhea, the medicine disclosed by the invention has the advantages that milking and milk vending of animal owners are not influenced during the milking period of cattle and sheep, the advantages are obvious, and a novel medication choice is provided for clinical treatment of livestock diarrhea diseases.

The invention relates to a medicine treating pancreatitis, which comprises the following components by weight percent: 10-30 brooklet anemone root, 5-15 dried ginger, 10-30 rhizoma arisaematis, 10-30 gentian, 10-30 purple bergenia, 10-30 knotweed rhizome and 10-30 giant knotweed rhizome. The invention has special efficacy on treating acute pancreatitis. The common patient can be cured after three-day administration and does not need operation. The pain and treatment expense of the patients is reduced. The invention has good treatment effect for the chronic pancreatitis, the treatment time is short and the treatment expense is low. The invention also has good efficacy for cholecystitis and digestive system diseases.

The invention provides an application of bergenin in preparation of a medicine for treating Klebsiella pneumoniae in vivo, and belongs to the technical field of biology and medicines. The invention proves that the bergenin can improve the cell survival rate reduction caused by Klebsiella pneumoniae infection, the cell oxidative damage caused by Klebsiella pneumoniae infection is improved, inflammatory response caused by Klebsiella pneumoniae infection is improved, lung injury caused by Klebsiella pneumoniae infection is improved, Klebsiella pneumoniae infection of lung is reduced, phosphorylation of ERK, JNK and p38 is inhibited and phosphorylation of I kappa B and p65 is inhibited so that Klebsiella pneumoniae infection is treated. The application is beneficial to further development andutilization of bergenin.

The invention discloses a compound oral administration preparation containing bergenin\cetirizine dihydrochloride, in particular to a gastric stasis floating type slow-release tablet, which mainly consists of a fast-release coating layer containing the cetirizine dihydrochloride and a slow-release tablet core layer containing the bergenin. The invention further realizes the fast release of the cetirizine dihydrochloride and the gastric stasis and the slow release of the bergenin, and improves the curative effect of the bergenin\cetirizine dihydrochloride compound oral administration preparation. Pharmacodynamic experiments prove that the medicine composition has the obvious effects of relieving the cough, eliminating the phlegm and preventing the asthma, has small side effect, and can be used for treating chronic bronchitis and bronchial asthma.

The invention discloses a Chinese medical preparation for treating yin deficiency and poison type perianal and perirectal abscesses. The traditional Chinese medicine composition is prepared from rhizome of whorledleaf solomonseal, cymbidium ensifolium, talinum crassifolium, oxhide gelatin, rhizome or herb of purple bergenia, ceylon helminthostachys rhizome, roots of barbate deadnettle, fig and liquorice. The Chinese medical preparation can be used for treating yin deficiency and poison type perianal and perirectal abscesses, pains of patients can be relieved, treatment course can be shortened, and patient compliance is high. The Chinese medical preparation has been used for treating 42 patients in the decoction form, wherein 24 patients are cured, 14 patients get better, 4 patients have not been cured yet, and total effective rate is 90.5%.